Oppenheimer & CO Inc Mirati Therapeutics, Inc. Transaction History

Oppenheimer & CO Inc

  • $6.42 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$75.82 - $150.97 $151,640 - $301,940
-2,000 Closed
0 $0
Q4 2021

Feb 02, 2022
SELL
$132.01 - $190.29 $4,620 - $6,660
-35 Reduced 1.72%
2,000 $293,000
Q4 2020

Feb 11, 2021
BUY
$162.05 - $240.27 $5,671 - $8,409
35 Added 1.75%
2,035 $447,000
Q2 2020

Aug 11, 2020
BUY
$72.01 - $120.39 $144,020 - $240,780
2,000 New
2,000 $228,000

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email